Effect of AD6 (8-monochloro-3-beta-diethylamino-ethyl-4-methyl-7-ethoxycarbonylme tho xy coumarin) on cyclic nucleotide phosphodiesterases in human platelets.
The effect of AD6 (8-monochloro-3-beta-diethylamino-ethyl-4-methyl-7-ethoxycarbonylmeth oxy coumarin), an inhibitor of platelet aggregation, on cyclic nucleotide metabolism was investigated. AD6 inhibited selectively human platelet cyclic GMP phosphodiesterase, which was separated from cyclic AMP phosphodiesterase by DEAE-cellulose chromatography. Addition of AD6 to washed platelets increased cyclic GMP levels significantly in two minutes. These results could be useful in elucidating the action of AD6 on intact platelets.
Hakim
G
G
Dipartimento di Biochimica, Università di Bologna, Italy.
Fiorentini
D
D
Falasca
A
A
Prosdocimi
M
M
Rossi
C A
CA
D015106:3',5'-Cyclic-GMP Phosphodiesterases / Q000037:antagonists & inhibitors*; D001792:Blood Platelets / Q000201:enzymology*; D002866:Chromonar / Q000031:analogs & derivatives / Q000494:pharmacology*; D003374:Coumarins / Q000494:pharmacology*; D006801:Humans; D009712:Nucleotides, Cyclic / Q000097:blood; D010726:Phosphodiesterase Inhibitors; D010727:Phosphoric Diester Hydrolases / Q000097:blood*
D003374:Coumarins; D009712:Nucleotides, Cyclic; D010726:Phosphodiesterase Inhibitors; C025945:cloricromen; D010727:Phosphoric Diester Hydrolases; D015106:3',5'-Cyclic-GMP Phosphodiesterases; D002866:Chromonar